Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-24-000293
Filing Date
2024-03-25
Accepted
2024-03-25 16:20:55
Documents
122
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20231231x10k.htm   iXBRL 10-K 2691784
2 EX-4.3 tmb-20231231xex4d3.htm EX-4.3 18814
3 EX-10.8 tmb-20231231xex10d8.htm EX-10.8 349778
4 EX-10.19 tmb-20231231xex10d19.htm EX-10.19 92508
5 EX-10.26 tmb-20231231xex10d26.htm EX-10.26 63863
6 EX-19.1 tmb-20231231xex19d1.htm EX-19.1 59427
7 EX-21.1 tmb-20231231xex21d1.htm EX-21.1 12943
8 EX-23.1 tmb-20231231xex23d1.htm EX-23.1 5435
9 EX-31.1 tmb-20231231xex31d1.htm EX-31.1 13694
10 EX-32.1 tmb-20231231xex32d1.htm EX-32.1 8359
11 EX-97.1 tmb-20231231xex97d1.htm EX-97.1 33295
12 GRAPHIC tmb-20231231x10k001.jpg GRAPHIC 46974
13 GRAPHIC tmb-20231231x10k002.jpg GRAPHIC 54975
14 GRAPHIC tmb-20231231xex10d8001.jpg GRAPHIC 631
15 GRAPHIC tmb-20231231xex10d8002.jpg GRAPHIC 641
16 GRAPHIC tmb-20231231xex10d8003.jpg GRAPHIC 661
17 GRAPHIC tmb-20231231xex10d8004.jpg GRAPHIC 631
18 GRAPHIC tmb-20231231xex10d8005.jpg GRAPHIC 631
19 GRAPHIC tmb-20231231xex10d8006.jpg GRAPHIC 663
20 GRAPHIC tmb-20231231xex10d8007.jpg GRAPHIC 644
21 GRAPHIC tmb-20231231xex10d8008.jpg GRAPHIC 647
22 GRAPHIC tmb-20231231xex10d8009.jpg GRAPHIC 679
23 GRAPHIC tmb-20231231xex10d8010.jpg GRAPHIC 688
24 GRAPHIC tmb-20231231xex10d8014.jpg GRAPHIC 660
25 GRAPHIC tmb-20231231xex10d8017.jpg GRAPHIC 675
26 GRAPHIC tmb-20231231xex10d8018.jpg GRAPHIC 631
27 GRAPHIC tmb-20231231xex10d8024.jpg GRAPHIC 680
28 GRAPHIC tmb-20231231xex10d8026.jpg GRAPHIC 679
29 GRAPHIC tmb-20231231xex10d8027.jpg GRAPHIC 645
30 GRAPHIC tmb-20231231xex10d8029.jpg GRAPHIC 681
31 GRAPHIC tmb-20231231xex10d8033.jpg GRAPHIC 673
32 GRAPHIC tmb-20231231xex10d8036.jpg GRAPHIC 630
33 GRAPHIC tmb-20231231xex10d8037.jpg GRAPHIC 630
34 GRAPHIC tmb-20231231xex10d8038.jpg GRAPHIC 673
35 GRAPHIC tmb-20231231xex10d8043.jpg GRAPHIC 672
36 GRAPHIC tmb-20231231xex10d8060.jpg GRAPHIC 675
37 GRAPHIC tmb-20231231xex10d8063.jpg GRAPHIC 663
38 GRAPHIC tmb-20231231xex10d8068.jpg GRAPHIC 688
39 GRAPHIC tmb-20231231xex10d8072.jpg GRAPHIC 1820
  Complete submission text file 0001410578-24-000293.txt   12310843

Data Files

Seq Description Document Type Size
40 EX-101.SCH tmb-20231231.xsd EX-101.SCH 78460
41 EX-101.CAL tmb-20231231_cal.xml EX-101.CAL 89528
42 EX-101.DEF tmb-20231231_def.xml EX-101.DEF 338442
43 EX-101.LAB tmb-20231231_lab.xml EX-101.LAB 690400
44 EX-101.PRE tmb-20231231_pre.xml EX-101.PRE 526740
126 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20231231x10k_htm.xml XML 1900275
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12584 | Film No.: 24779484
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)